3.35
price up icon1.21%   0.04
after-market After Hours: 3.35
loading
Allurion Technologies Inc stock is traded at $3.35, with a volume of 183.82K. It is up +1.21% in the last 24 hours and up +5.35% over the past month. Allurion Technologies Inc is a medical device company that focuses on creating a best-in-class weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.
See More
Previous Close:
$3.31
Open:
$3.45
24h Volume:
183.82K
Relative Volume:
0.07
Market Cap:
$19.98M
Revenue:
$34.75M
Net Income/Loss:
$-24.76M
P/E Ratio:
-0.2792
EPS:
-12
Net Cash Flow:
$-50.91M
1W Performance:
+7.37%
1M Performance:
+5.35%
6M Performance:
-80.58%
1Y Performance:
-93.02%
1-Day Range:
Value
$3.18
$3.45
1-Week Range:
Value
$2.72
$3.4985
52-Week Range:
Value
$2.15
$98.75

Allurion Technologies Inc Stock (ALUR) Company Profile

Name
Name
Allurion Technologies Inc
Name
Phone
508-647-4000
Name
Address
11 HURON DR STE 200, NATICK
Name
Employee
24
Name
Twitter
Name
Next Earnings Date
2024-12-13
Name
Latest SEC Filings
Name
ALUR's Discussions on Twitter

Compare ALUR with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Medical Devices icon
ALUR
Allurion Technologies Inc
3.35 19.98M 34.75M -24.76M -50.91M -12.00
Medical Devices icon
ABT
Abbott Laboratories
131.93 228.81B 41.95B 13.40B 6.35B 7.65
Medical Devices icon
BSX
Boston Scientific Corp
100.05 149.74B 16.75B 1.85B 2.37B 1.25
Medical Devices icon
SYK
Stryker Corp
377.46 142.48B 22.60B 2.99B 3.49B 7.76
Medical Devices icon
MDT
Medtronic Plc
88.86 113.49B 33.20B 4.26B 5.47B 3.29
Medical Devices icon
EW
Edwards Lifesciences Corp
72.05 42.10B 5.72B 4.17B 259.90M 6.97

Allurion Technologies Inc Stock (ALUR) Upgrades & Downgrades

Date Action Analyst Rating Change
Nov-14-24 Downgrade Chardan Capital Markets Buy → Neutral
Oct-02-24 Initiated TD Cowen Buy
Sep-06-24 Initiated ROTH MKM Buy
Feb-09-24 Initiated Jefferies Buy

Allurion Technologies Inc Stock (ALUR) Latest News

pulisher
Apr 01, 2025

Allurion Technologies CEO Gaur Shantanu acquires $26,800 in stock By Investing.com - Investing.com Canada

Apr 01, 2025
pulisher
Apr 01, 2025

Allurion Technologies CEO Gaur Shantanu acquires $26,800 in stock - Investing.com India

Apr 01, 2025
pulisher
Apr 01, 2025

Allurion Technologies CEO Acquires 8,000 Shares - TradingView

Apr 01, 2025
pulisher
Mar 31, 2025

12 Consumer Discretionary Stocks Moving In Monday's After-Market Session - Benzinga

Mar 31, 2025
pulisher
Mar 28, 2025

Allurion Technologies’ Earnings Call: Growth Amid Challenges - TipRanks

Mar 28, 2025
pulisher
Mar 27, 2025

Chardan holds Allurion stock at Neutral with a $2.50 target By Investing.com - Investing.com South Africa

Mar 27, 2025
pulisher
Mar 27, 2025

Chardan holds Allurion stock at Neutral with a $2.50 target - Investing.com

Mar 27, 2025
pulisher
Mar 27, 2025

Allurion Technologies Inc (ALUR) Q4 2024 Earnings Call Highlights: Strategic Restructuring and ... By GuruFocus - Investing.com Canada

Mar 27, 2025
pulisher
Mar 27, 2025

Allurion Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update - BioSpace

Mar 27, 2025
pulisher
Mar 26, 2025

TD Cowen Cuts Allurion Technologies' Price Target to $6 From $16, Buy Rating Maintained - MarketScreener

Mar 26, 2025
pulisher
Mar 26, 2025

Allurion Technologies, Inc. (ALUR) Reports Q4 Loss, Lags Revenue Estimates - MSN

Mar 26, 2025
pulisher
Mar 26, 2025

Earnings call transcript: Allurion Technologies’ Q4 2024 shows revenue drop, strategic shifts By Investing.com - Investing.com South Africa

Mar 26, 2025
pulisher
Mar 26, 2025

Earnings call transcript: Allurion Technologies’ Q4 2024 shows revenue drop, strategic shifts - Investing.com

Mar 26, 2025
pulisher
Mar 26, 2025

Allurion Technologies Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 26, 2025
pulisher
Mar 26, 2025

ALLURION TECHNOLOGIES Earnings Results: $ALUR Reports Quarterly Earnings - Nasdaq

Mar 26, 2025
pulisher
Mar 26, 2025

Earnings Scheduled For March 26, 2025 - Benzinga

Mar 26, 2025
pulisher
Mar 26, 2025

Allurion Technologies Reports 2024 Financial Results and Outlook - TipRanks

Mar 26, 2025
pulisher
Mar 25, 2025

What To Expect From Allurion Technologies Inc (ALUR) Q4 2024 Earnings - Yahoo Finance

Mar 25, 2025
pulisher
Mar 22, 2025

Allurion surges on weight loss data from gastric balloon, GLP-1 combo treatment - MSN

Mar 22, 2025
pulisher
Mar 21, 2025

Gold Down Over 1%; Micron Technology Shares Fall After Q2 Earnings - Benzinga

Mar 21, 2025
pulisher
Mar 21, 2025

Allurion Stock Soars on Promising GLP-1 Combo Results - Wall Street Pit

Mar 21, 2025
pulisher
Mar 21, 2025

Promising Potential of Allurion Technologies’ Innovative Approach Supports Buy Rating - TipRanks

Mar 21, 2025
pulisher
Mar 21, 2025

Why Ouster Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket - Benzinga

Mar 21, 2025
pulisher
Mar 21, 2025

US Stocks Likely To Open Lower, But 'Economic Conditions Don't Signal A Downturn,' Say Analysts As They Expect 'Resilient Earnings' To Lift EquitiesAllurion Technologies (NYSE:ALUR), Accenture (NYSE:ACN) - Benzinga

Mar 21, 2025
pulisher
Mar 20, 2025

Allurion reports weight loss and muscle gain with new therapy By Investing.com - Investing.com South Africa

Mar 20, 2025
pulisher
Mar 20, 2025

Allurion Technologies Reports Positive Ballon Combination Study Results; Shares Jump - MarketScreener

Mar 20, 2025
pulisher
Mar 20, 2025

Allurion Announces Initial Results on the Combination of the Allurion Program With Low-dose GLP-1 Therapy to Optimize Muscle Mass and GLP-1 Adherence - BioSpace

Mar 20, 2025
pulisher
Mar 20, 2025

12 Consumer Discretionary Stocks Moving In Thursday's After-Market Session - Benzinga

Mar 20, 2025
pulisher
Mar 20, 2025

Allurion reports weight loss and muscle gain with new therapy - Investing.com India

Mar 20, 2025
pulisher
Mar 20, 2025

Revolutionary Weight Loss Results: Allurion Balloon Plus Low-Dose GLP-1 Shows 20% Weight Loss, Preserves Muscle - StockTitan

Mar 20, 2025
pulisher
Mar 20, 2025

Analysts Offer Insights on Healthcare Companies: Allurion Technologies (ALUR) and Esperion (ESPR) - The Globe and Mail

Mar 20, 2025
pulisher
Mar 17, 2025

ALLURION TECHNOLOGIES Earnings Preview: Recent $ALUR Insider Trading, Hedge Fund Activity, and More - Nasdaq

Mar 17, 2025
pulisher
Mar 17, 2025

Allurion’s Next-Generation Weight Loss Device Earns New Patents - MPO-mag

Mar 17, 2025
pulisher
Mar 13, 2025

Allurion Technologies (ALUR) Projected to Post Quarterly Earnings on Thursday - Defense World

Mar 13, 2025
pulisher
Mar 12, 2025

Allurion to Report Fourth Quarter 2024 Financial Results on March 26, 2025 - The Joplin Globe

Mar 12, 2025
pulisher
Mar 10, 2025

Q1 EPS Forecast for Allurion Technologies Cut by Analyst - Defense World

Mar 10, 2025
pulisher
Mar 05, 2025

Allurion Technologies price target lowered to $16 on split-adjusted basis - TipRanks

Mar 05, 2025
pulisher
Mar 05, 2025

Allurion Balloon Reintroduced in France - MPO-mag

Mar 05, 2025
pulisher
Mar 05, 2025

Allurion Announces Notification of Issuance of New U.S. Patents on Next-Generation Weight Loss Device for the Treatment of Obesity - BioSpace

Mar 05, 2025
pulisher
Mar 04, 2025

Allurion Technologies announces issuance of new patents on weight loss device - TipRanks

Mar 04, 2025
pulisher
Mar 04, 2025

Allurion Announces Notification Of Issuance Of New U.S. Patents On Next-Generation Weight Loss Device For The Treatment Of Obesity - Marketscreener.com

Mar 04, 2025
pulisher
Feb 25, 2025

Allurion to Participate in Upcoming Investor Conferences - 01Net

Feb 25, 2025
pulisher
Feb 25, 2025

Allurion to Participate in Upcoming Investor Conferences -February 25, 2025 at 04:06 pm EST - Marketscreener.com

Feb 25, 2025
pulisher
Feb 25, 2025

Can Allurion's Anti-Obesity Strategy Impress Investors at Major Healthcare Conferences? - StockTitan

Feb 25, 2025
pulisher
Feb 23, 2025

ALURALLURION TECHNOLOGIES INC Latest Stock News & Market Updates - StockTitan

Feb 23, 2025
pulisher
Feb 20, 2025

Allurion to raise $6.1 million in direct offering and private placement - MSN

Feb 20, 2025
pulisher
Feb 20, 2025

Allurion Announces Closing of Offering and Concurrent Private Placement to Advance GLP-1 Clinical Pipeline - BioSpace

Feb 20, 2025
pulisher
Feb 20, 2025

Can Allurion's Balloon-GLP-1 Combo Reshape Weight Loss Treatment? $6.1M Bet Says Yes - StockTitan

Feb 20, 2025
pulisher
Feb 20, 2025

Allurion announces $6.1 million stock and warrant sale By Investing.com - Investing.com South Africa

Feb 20, 2025
pulisher
Feb 19, 2025

Allurion announces $6.1 million stock and warrant sale - Investing.com

Feb 19, 2025
pulisher
Feb 19, 2025

Allurion Tech dips on $6.1 million stock offering - TradingView

Feb 19, 2025

Allurion Technologies Inc Stock (ALUR) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
medical_devices STE
$227.57
price up icon 0.82%
medical_devices ZBH
$112.50
price up icon 0.12%
medical_devices PHG
$24.84
price down icon 1.55%
$68.14
price up icon 1.22%
$79.36
price down icon 0.26%
medical_devices EW
$72.05
price up icon 0.25%
Cap:     |  Volume (24h):